Kirolous Makarious, Pharm D, Mb Ac
About Kirolous Makarious, Pharm D, Mb Ac
Kirolous Makarious, Pharm.D., Mb Ac, is the Associate Director and Solid Tumor Oncology Congress Strategy Lead at Bristol Myers Squibb.
Title
Kirolous Makarious currently holds the position of Associate Director, Solid Tumor Oncology Congress Strategy Lead at Bristol Myers Squibb. In this role, he is responsible for the strategic planning and execution of oncology congresses that focus on solid tumors.
Company
Kirolous Makarious is associated with Bristol Myers Squibb, a prominent company in the pharmaceutical industry. His work at Bristol Myers Squibb involves leading efforts related to oncology congresses specifically focusing on solid tumors.
Previous Experience at Merck
Before his current role, Kirolous Makarious worked at Merck as a Senior Clinical Scientist Oncology from 2020 to 2021. During this period, he contributed to clinical research and development within the field of oncology.
Previous Experience at Rutgers Pharmaceutical Industry Fellowship (RPIF) Program
From 2018 to 2020, Kirolous Makarious was a Clinical Science and Study Management Post-Doctoral Fellow at the Rutgers Pharmaceutical Industry Fellowship (RPIF) Program in the Greater New York City Area. This fellowship provided him with in-depth experience in clinical science and study management.
Education and Expertise
Kirolous Makarious earned his Doctor of Pharmacy (Pharm.D.) from Touro College of Pharmacy, completing his studies there from 2014 to 2018. He also holds a Bachelor's Degree in Biochemistry from Seton Hall University, where he studied from 2010 to 2013. Additionally, he has furthered his education through the Rutgers University Pharmaceutical Industry Program.